Rafferty Asset Management, LLC

Position in OCGN — Ocugen, Inc.

CIK 1389426 New York, NY

Position in OCGN

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$594,825

+$82,773 QoQ

Shares Held

388,775

+37.4% QoQ

Ownership

0.115%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#30

of 147 holders

Holding Since

Mar 2021

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Rafferty Asset Management, LLC holds $335,902,097 across 164 Biotechnology names. OCGN ranks #111 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	65,798	$32,683,840
2	REGN	Regeneron Pharmaceuticals, Inc.	38,534	$24,027,490
3	ALNY	Alnylam Pharmaceuticals, Inc.	55,332	$16,656,591
4	MRNA	Moderna, Inc.	111,906	$7,836,777
5	INCY	Incyte Corp	44,663	$5,062,997
6			33,369	$4,429,067
7	TWST	Twist Bioscience Corp	40,732	$4,190,508
8	ORKA	Oruka Therapeutics, Inc.	43,110	$4,102,778

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$594,825	388,775	+37.4%	Shares	Sole	2026-08-14
2026-03-31	$512,052	282,902	-64.5%	Shares	Sole	2026-05-15
2024-09-30	$790,952	797,331	-26.0%	Shares	Sole	2024-11-13
2024-06-30	$1,669,415	1,077,042	-56.4%	Shares	Sole	2024-08-13
2022-12-31	$3,212,521	2,471,170	+27.8%	Shares	Sole	2023-02-13
2022-09-30	$3,442,354	1,933,907	+39.6%	Shares	Sole	2022-11-14
2022-06-30	$3,145,616	1,385,734	-36.5%	Shares	Sole	2022-08-12
2022-03-31	$7,202,250	2,182,500	+121.4%	Shares	Sole	2022-05-13
2021-12-31	$4,484,684	985,645	+126.2%	Shares	Sole	2022-02-10
2021-09-30	$3,129,072	435,804	+5.9%	Shares	Sole	2021-11-10
2021-06-30	$3,303,806	411,433	+23.5%	Shares	Sole	2021-08-10
2021-03-31	$2,262,298	333,181	—	Shares	Sole	2021-05-10
No filing history on record for this holder in this stock.